Background: The use of gentamicin places patients at risk of developing drug-induced nephrotoxicity, requiring special consideration to be given to serum creatinine monitoring and therapeutic drug monitoring (TDM).Mason, T.Verley, M.Gossell-Williams, M.Thorbourne, A.Walcott-Mitchell, A.Hoe, K....
Recently, the use of gentamicin-loaded microparticles and the use of new antibiotics, such as tigecycline, may hold future promise. In addition, there are a few studies of the enhanced effect of immune response stimulators, such as levimasole and IFN-2, in the treatment of brucellosis. The ...
The latest pilot clinical study (ClinicalTrials.gov; id: NCT02698735) has shown positive results of gentamicin use in recessive dystrophic epidermolysis bullosa patients with nonsense mutation in the gene encoding type VII collagen. Topical or intradermal administration of gentamicin increased the level ...
Once the cavity surface was thoroughly cleansed, a solution consisting of 50 ml of sterile saline and 240,000 units of gentamicin was injected into the abscess cavity. Finally, a thin drainage tube was clipped in place before the incision was sutured (Fig. 4A-C). Fig. 3 Clinical images ...
8.Gentamicin Enema Combined with Yunnan Baiyao in Treatment of Suppurative Enteritis庆大霉素加云南白药灌肠治疗化脓性肠炎 9.2% iodine glycerin, diluted adrenalin solution or Yunnanbaiyao were used to prevent and treat oral cavity bleeding.用2 %碘甘油、肾上腺素稀释液或云南白药防治口腔出血。
(i.e.,vancomycin, gentamicin) and other medications have found strong correlations between drug concentrations in the blood/serum and the ISF (Ranamukhaarachchi et al., 2016). Due to the low amount of interstitial fluid in the skin (about 20nL/mm2in the epidermis and approximately 80...
We also use optional cookies for advertising, personalisation of content, usage analysis, and social media. By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with...
Disclosed is the therapeutic use of CpG oligodeoxynucleotides for skin diseases. The CpG oligodeoxynucleotides (CpG ODNs) of the present invention show excellent immunoactive effects against skin diseases in both cases of CpG ODNs with a phosphorothioate backbone and CpG ODNs with a phosphodiester ...
Further, it is another object of the invention to provide a pharmaceutical or therapeutical composition comprising an agonist ligand specific to G2A receptor as an active ingredient for use according to the claims. It is still another object of the invention to provide a novel therapeutic use of...
The present invention relates to novel siRNA molecules which inhibit the RTP801 gene and to the use of such molecules to treat respiratory disorders of all types (including pulmonary disorders), eye diseases and conditions, microvascular disorders, angiogenesis- and apoptosis-related conditions, and he...